[Expression of nm23-H(1) mRNA in Bone Marrow Cells from Patients with Myelodysplastic Syndrome and Its Clinical Implication].

Zhongguo Shi Yan Xue Ye Xue Za Zhi

Department of Hematology, Affiliated Hospital of Medical College, Qingdao University, Qingdao 266003, China.

Published: June 2001

The purpose of this investigation was to explore the expression of nm23-H(1) gene in patients with myelodysplastic syndrome (MDS) and evaluate the relationship between nm23-H(1) expression and therapeutic outcomes. Semi-quantitative RT-PCR was used to detect the expression of nm23-H(1) mRNA in marrow mononuclear cells from 28 MDS patients and 15 normal subjects. nm23-H(1)/GAPDH ratio >/= 0.5 was believed to a positive case. The expression of nm23-H(1) was positive in 24 of 28 MDS patients, and the average level was 0.89 +/- 0.56. nm23-H(1) mRNA was negative in normal controls. The overexpression of nm23-H(1) mRNA in MDS patients could predict outcome of treatment and prognosis for MDR patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nm23-h1 mrna
16
expression nm23-h1
12
mds patients
12
patients myelodysplastic
8
myelodysplastic syndrome
8
patients
6
nm23-h1
6
[expression nm23-h1
4
mrna
4
mrna bone
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!